Citius Pharmaceuticals (CTXR) announced that it has entered into definitive agreements for the purchase of an aggregate of 12M shares of its ...

Net income: US$627.0k (up from US$579.0k loss in 3Q 2023). Profit margin: 6.1% (up from net loss in 3Q 2023). The move to ...

It's been a sad week for Marinus Pharmaceuticals, Inc. ( NASDAQ:MRNS ), who've watched their investment drop 14% ...

After reaching a $6.01 billion deal with 3M to settle the largest mass tort litigation in U.S. history, lawyers for the ...

The company will not receive any proceeds from the resale of the shares by the selling stockholders in this offering. Published first on ...

The United States Agency for International Development has announced a $2.3m commitment to procure 4.8 million doses of ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...

Oct 22 (Reuters) - 3M Co (MMM.N), opens new tab raised its full-year profit forecast on Tuesday after strong demand for roofing material, industrial adhesives and electronics equipment helped the ...

Ratings for ANI Pharmaceuticals ANIP were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings ...

My most recent article on the stock was written on July 2, titled "3M: A Dividend Cutter With A Strong Buy Rating." The company has returned 32% since then. With that said, I cannot blame ...